Rat plasma fibronectin has been isolated and characterized and monospecific antibodies were prepared to it. Two components of fresh rat plasma (in the presence of proteinase inhibitors) bound to a gelatin-Sepharose affinity column. One protein was eluted with 4.0M-urea and was identified as fibronectin. Another protein was eluted from the gelatin-Sepharose column with 8.0M-urea and was identified as a 70000-M, collagenbinding molecule. This 70000-Mr fragment was found to be a normal constituent of blood plasma, and its presence did not represent a proteolytic degradation product formed during isolation. The antibodies prepared against rat fibronectin only weakly cross-reacted with plasma fibronectins of chicken, horse and human. These studies shed light on the metabolic interrelationships between fibronectin and other collagen-binding molecules.
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Fibronectin is a pericellular glycoprotein involved in extracellular matrix-cell interaction (Hynes, 1976; Vaheri et al., 1978; Yamada & Olden, 1978; Kleinmann et al., 1979; Pearlstein et al., 1980) . A structurally related and immunologically crossreactive protein, plasma fibronectin, occurs in the circulating blood plasma and was previously known as 'cold-insoluble globulin' (Mosesson, 1978; Yamada & Kennedy, 1979) . During the course of our investigation of collagenous matrix-cell interactions in vivo (Reddi, 1976) , we described the importance of fibronectin in the early stages of mesenchymal-cell proliferation (Weiss & Reddi, 1980 , 1981 . We realized that despite the use of the rat in numerous experimental studies on matrix-cell interactions, there was a paucity of information on the chemical characterization of rat fibronectin. In view of this we have isolated and characterized the 'rat plasma fibronectin.
Materials and methods -Isolation ofplasmafibronectin
Gelatin-Sepharose chromatography. Pig skin gelatin (Sigma) was coupled to Sepharose 4B Vol. 197 (Pharmacia) at 560C in 1.0M-NaCl/0.5M-H3BO3, pH 9.0 to prepare the gelatin-Sepharose affinity column (as described by Engvall & Ruoslahti, 1972) . The pig skin gelatin was dissolved in the above buffer at 560C (lmg/ml) and then centrifuged to remove undissolved particles. The Sepharose 4B was activated by pretreating with CNBr (Cuatrecasas, 1970) . The collagen solution was mixed with the gel slurry for 3 h at 560C. The reaction was stopped with 1.0 M-ethanolamine, pH8.0, for 2h. The gelatin-Sepharose was then washed alternately with 0.1 M-sodium acetate, pH4, and 0.1M-H3B03, pH9, for four cycles. The gel was then equilibrated with 0.02 M-NaH2PO4/ 0.15M -NaCl / 0.5mm -phenylmethanesulphonyl fluoride before use. Freshly obtained rat plasma, with EDTA as an anticoagulant, and chilled on ice immediately after exsanguination, was applied to the gelatin-Sepharose column (4x25cm; 75ml of plasma). Phenylmethanesulphonyl fluoride (0.5 mm final concn.) was used with EDTA in blood-collection tubes. The eluant was monitored for protein by absorbance at 280nm. The column was Gelfiltration. The peak that was eluted by 4.0M-urea from the gelatin-Sepharose affinity column was dialysed against 20 vol. of water at 40C for 48 h and was then rechromatographed on Sepharose 4B-CL (0.9cm x 90cm column) with an eluting buffer containing 0.02M-NaH2PO4/0.15 M-NaCl/0.5 mMphenylmethanesulphonyl fluoride, pH7.4 at 220C. The proteins were monitored for A280.
Gel electrophoresis. Samples were subjected to 0.1% SDS/5%-polyacrylamide-gel electrophoresis (Laemmli, 1970) , vertical slab gels (1.5mm thick) being used. Samples were heated in a boiling-water bath for 5 min with 0.1 M-f-mercaptoethanol, 0.1% SDS and glycine/Tris electrode buffer, pH 8.8.
Amino acid analysis. Samples were dissolved in constant-boiling 6 M-HCI in a N2 atmosphere and then hydrolysed at 1060C for 24h.
Preparation ofantibodies
Production of the antiserum. The freeze-dried preparation eluted by 4 M-urea from the gelatin-Sepharose columns was treated for 5 min in a boiling-water bath in sample buffer (0.1 M-4-mercaptoethanol/0.1% SDS/1.0% glycerol/glycine/ Tris/HCl electrode buffer, pH 8.5), and then subjected to preparative 0.1% SDS/5%-polyacrylamide-gel electrophoresis. Gel slices containing fibronectin were then homogenized with incomplete Freund's Adjuvant and injected into male New Zealand rabbits. Booster injections were given 2 and 4 weeks later.
Isolation of purified antifibronectin antibodies.
The freeze dried preparation eluted by 4.0M-urea, containing the fibronectin, was further purified by preparative electrophoresis. This purified fibronectin, from the gelatin-Sepharose column, was coupled to CNBr-activated Sepharose 4B at 40C in 0.5 M-H3B03/1.OM-NaCl for 15 h with gentle agitation. The antiserum (20ml) was applied to the fibronectin-Sepharose affinity column (1.5 cm x 12cm) at 40C. The column was washed with buffer containing 0.002% NaN3, 0.05 M-Tris/HCl and 0.15M-NaCl, pH 7.5. The eluant was monitored for protein by absorbance at 280nm. The fibronectin specific antibody was eluted with 3.0M-KSCN, 0.02M-NaH2PO4, pH 6.0. The antibody was then immediately dialysed against phosphate-buffered saline (0.02M-NaH2PO4/0.15 M-NaCl) at 40C. Antibody cross-reactivity
The antibodsy specificity was monitored by the Ouchterlony immunodIffusion technique. The antibody was placed in the centre well whereas soluble rat fibronectin preparations, and rat Types I and II collagens, rat fibrin and rat albumin were placed in the surrounding wells.
The species specificity of the anti-(rat fibronectin) antibody was tested by comparing horse, chicken and human fibronectins. Sera of the animals were commercially obtained (Gibco) and the human serum from the National Institutes of Health blood bank, subjected to gelatin-Sepharose affinity chromatography and the fibronectin isolated as described above. An enzyme-linked immunoabsorbent assay ('ELISA') was used to assess the cross-reactivity (Rennard et al., 1980) . The degree of competitive inhibition of the rat specific antibody and the rat fibronectin with non-rat fibronectins were observed.
The ELISA assay used was similar to that described by Rennard et al. (1980) and Vuento & Vaheri (1978) . Immulon micro-ELISA plates (Dynatech) were coated with 100-200ng of purified rat plasma fibronectin per well. The species-specific fibronectin was incubated with the purified rabbit antibody to rat plasma fibronectin for 60min in phosphate-buffered saline with 0.05% Tween 20. The soluble antigen-antibody mixture was then placed in the micro-ELISA wells and incubated for 60min. After washing, peroxidase conjugated anti-(rabbit IgG) made in goat (Miles) was placed in the wells for 60min. After washing, a substrate solution containing H202 and o-phenylenediamine was added. The reaction was stopped with 8.0M-H2SO4 and the absorbance read at 480nm. A standard curve was constructed with purified rat plasma fibronectin and was used to calculate the plasma fibronectin concentration.
Immunofluorescent staining. Tissue pieces from rat skin, spleen, liver and kidney were immediately placed on solid CO2 (-700C) and then frozen, unfixed, in O.C.T. embedding medium (Miles). Frozen sections (6,um thick) were cut in a cryostat at -200C within 3 h of autopsy. The protein concentration of the antibody solution was 20,ug/ml as determined by the Lowry et al. (1951 procedure) .
After incubation, the sections were washed three times for 5min each in phosphate-buffered saline, then air-dried. The sections were incubated for. 30min at 220C with fluorescein isothiocyanateconjugated goat antibodies to rabbit IgG (diluted_ 1:20 with phosphate-buffered saline; Miles). A control was observed for each tissue by using preimmune rabbit sera as the first incubating solution. Another control, which consisted of preabsorbing the antibody with purified antigen, yielded no fluorescence.
Results
The elution profile from the gelatin-Sepharose affinity column is shown in Fig. 1 . The peaks were analysed by gel electrophoresis under reducing conditions (Fig. 2) , and apparent molecular weights were determined. The material eluted by 4.0M-urea Fraction no. Fig. 1 . Gelatin-Sepharose affinity chromatographv offibronectin from rat plasma
Fresh rat plasma was passed through a gelatin-Sepharose affinity column and the eluant was monitored for protein absorbance at 280nm (ordinate). The column was then washed with 4.0M-urea and 8.0M-urea (arrows) (see the Materials and methods section for the complete procedure).
(a.) (Table 1) . Amino acid composition of the protein eluted by 8.0 M-urea was similar to the 70000-Mr collagen-binding fragment reported by Balian et al. (1979) .
The material eluted by 4.0 M-urea from the gelatin-Sepharose affinity column was chromatographed on a Sepharose 4B CL column, 0.02M-NaH2PO4/0. 15M-NaCI, pH 7.5, being used as the eluting buffer (Fig. 3) . Four peaks were separated and the amino acid compositions of these fractions are given in Table 2 .
The material eluted by 4.0 M-urea from the gelatin-Sepharose affinity column was electrophoresed (5%-polyacrylamide slab gels containing 0.1% SDS) under reducing conditions. The fibronectin band was sliced and used for production of antiserum as described in the Materials and methods section. The two bands in the material eluted by 4M-urea were separated by preparative electrophoresis. The purified fibronectin was coupled to CNBr-activated Sepharose 4B and the anti-fibronectin antiserum was passed through the column. The monospecific antibody was eluted with 3.0M-KSCN (see the chromatogram in Fig. 4) .
The antibody did not cross-react with Types I or II collagens, albumin or fibrin, as determined by immunodiffusion or the ELISA technique. Fibronectins from chicken, horse and human only weakly cross-reacted with the antibody made against rat plasma fibronectin (Fig. 5) . The fraction eluted by 8.0M-urea from the gelatin-Sepharose affinity column (the 70000Mr protein) weakly cross-reacted with the antibody (Fig. 5) .
In order to further assess the specificity of the antibody, it was used to localize fibronectin in various rat tissues. Fibronectin was absent from the epidermis, but present in the dermis (Plate la). The antigen was also present in the glomerulus of the kidney (Plate lb), and the connective tissue of the spleen (Plate 1 c). Fibronectin could be seen The BiochemicalJournal, Vol. 197, No. 3 (a) Plate 1
Immunofluorescence localization offibronectin infreshfrozen sections ofrat liver tissues (magnification x250) (a) Skin: fibronectin is absent from the epidermis (E), but present in the dermis, associated with blood vessels (arrow); (b) kidney: fibronectin is absent from the tubule cells (T) but present in the glomerulus (G) and connective tissues; (c) body agrees with the previous reports of the nature of the collagen-binding fragment, but also suggests that the 70000-Mr protein may not be derived from fibronectin (i.e. if the antigenic site is associated with the collagen-binding fragment). The possibility that the 70000-M, protein may arise as a proteolytic artefact was next examined. In an effort to inhibit proteinase activity, phenylmethanesulphonyl fluoride was used in all eluting buffers and only fresh plasma was used and processed the same day. Despite the use of EDTA and phenylmethanesulphonyl fluoride together in the blood collection tubes, the 70000-M, fragment was still present. In numerous tissues there may be more than one fibronectin-related or fibronectin-unrelated molecules that have the ability to bind to collagen. In fact the differences seen in amino acid composition between the 70000-Mr collagen-binding fragment of human fibronectin and the 7O000-M, protein presently described suggest that this molecule is a distinct collagen-binding protein unrelated to fibronectin. Whatever the source of this protein, these data indicate that the 7O000-M, protein has a higher affinity for gelatin than fibronectin and may be present in the blood plasma as a separate entity from fibronectin.
Other peaks produced by Sepharose 4B-Cl ultrafiltration may represent other gelatin-binding components. Future studies may shed more light on the metabolic interrelationships between fibronectin and other fragments of fibronectin in a variety of biological functions (Gold & Pearlstein, 1980; Yamada et al., 1980) .
